Inventor · disambiguated record
Elena Orlando
Also filed as: ORLANDO ELENA
4 granted patents·6 pending applications·54 citations·filing 2015–2023
77Inventor score
Files withNOVARTIS AG10
Top patents by PatentIndex Score
10 records- 0196US10253086B2CD20 therapies, CD22 therapies, and combination therapies with a CD19 chimeric antigen receptor (CAR)-expressing cellNOVARTIS AG·Filed 2016·Granted Apr 9, 2019·37 cites·35 claims
- 0294US11149076B2CD20 therapies, CD22 therapies, and combination therapies with a CD19 chimeric antigen receptor (CAR)-expressing cellNOVARTIS AG·Filed 2019·Granted Oct 19, 2021·9 cites·32 claims
- 0391US10774388B2Biomarkers predictive of therapeutic responsiveness to chimeric antigen receptor therapy and uses thereofNOVARTIS AG·Filed 2015·Granted Sep 15, 2020·7 cites·31 claims
- 0489US12344657B2CD20 therapies, CD22 therapies, and combination therapies with a CD19 chimeric antigen receptor (CAR)-expressing cellNOVARTIS AG·Filed 2021·Granted Jul 1, 2025·1 cites·27 claims
- 0580US2023374105A1Cd20 therapies, cd22 therapies, and combination therapies with a cd19 chimeric antigen receptor (car)-expressing cellNOVARTIS AG·Filed 2023·Application pending·0 cites
- 0662US2021172020A1Biomarkers predictive of therapeutic responsiveness to chimeric antigen receptor therapy and uses thereofNOVARTIS AG·Filed 2020·Application pending·0 cites
- 0756US2020370012A1Methods of making chimeric antigen receptor-expressing cellsNOVARTIS AG·Filed 2018·Application pending·0 cites
- 0847US2021213063A1Combination therapy with chimeric antigen receptor (car) therapiesNOVARTIS AG·Filed 2019·Application pending·0 cites
- 0946US2023332104A1Zbtb32 inhibitors and uses thereofNOVARTIS AG·Filed 2021·Application pending·0 cites
- 1044US2021396739A1Biomarkers for evaluating car-t cells to predict clinical outcomeNOVARTIS AG·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Elena Orlando files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →